Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 574

1.

Overcoming challenges in treating autoimmuntity: Development of tolerogenic immune-modifying nanoparticles.

Pearson RM, Podojil JR, Shea LD, King NJ, Miller SD, Getts DR.

Nanomedicine. 2018 Oct 21. pii: S1549-9634(18)30538-0. doi: 10.1016/j.nano.2018.10.001. [Epub ahead of print] Review.

PMID:
30352312
2.

Randomized Controlled Trial of Micronized Dehydrated Human Amnion/Chorion Membrane (dHACM) Injection Compared to Placebo for the Treatment of Plantar Fasciitis.

Cazzell S, Stewart J, Agnew PS, Senatore J, Walters J, Murdoch D, Reyzelman A, Miller SD.

Foot Ankle Int. 2018 Oct;39(10):1151-1161. doi: 10.1177/1071100718788549. Epub 2018 Jul 30.

PMID:
30058377
3.

Psychometric Properties of the Outcome Rating Scale (ORS) in a Spanish Clinical Sample.

Moggia D, Niño-Robles N, Miller SD, Feixas G.

Span J Psychol. 2018 Jul 30;21:E30. doi: 10.1017/sjp.2018.32.

PMID:
30056820
4.

Randomized dose-ranging study of a budesonide metered-dose inhaler by using co-suspension delivery technology in asthma.

Miller SD, Nyberg J, Siddiqui S, Dorinsky P, St Rose E, Reisner C.

Allergy Asthma Proc. 2018 Sep 23;39(5):350-358. doi: 10.2500/aap.2018.39.4155. Epub 2018 Jul 23.

PMID:
30037361
5.

The Use of Biodegradable Nanoparticles for Tolerogenic Therapy of Allergic Inflammation.

Smarr CB, Miller SD.

Methods Mol Biol. 2018;1799:353-358. doi: 10.1007/978-1-4939-7896-0_25.

PMID:
29956163
6.

B7-H4 Modulates Regulatory CD4+ T Cell Induction and Function via Ligation of a Semaphorin 3a/Plexin A4/Neuropilin-1 Complex.

Podojil JR, Chiang MY, Ifergan I, Copeland R, Liu LN, Maloveste S, Langermann S, Liebenson D, Balabanov R, Chi H, Chen L, Vignali DAA, Miller SD.

J Immunol. 2018 Aug 1;201(3):897-907. doi: 10.4049/jimmunol.1700811. Epub 2018 Jun 13.

PMID:
29898965
7.

Peripherally derived T regulatory and γδ T cells have opposing roles in the pathogenesis of intractable pediatric epilepsy.

Xu D, Robinson AP, Ishii T, Duncan DS, Alden TD, Goings GE, Ifergan I, Podojil JR, Penaloza-MacMaster P, Kearney JA, Swanson GT, Miller SD, Koh S.

J Exp Med. 2018 Apr 2;215(4):1169-1186. doi: 10.1084/jem.20171285. Epub 2018 Feb 27.

8.

APOBEC-mediated mutagenesis in urothelial carcinoma is associated with improved survival, mutations in DNA damage response genes, and immune response.

Glaser AP, Fantini D, Wang Y, Yu Y, Rimar KJ, Podojil JR, Miller SD, Meeks JJ.

Oncotarget. 2017 Dec 16;9(4):4537-4548. doi: 10.18632/oncotarget.23344. eCollection 2018 Jan 12.

9.

ILDR2 Is a Novel B7-like Protein That Negatively Regulates T Cell Responses.

Hecht I, Toporik A, Podojil JR, Vaknin I, Cojocaru G, Oren A, Aizman E, Liang SC, Leung L, Dicken Y, Novik A, Marbach-Bar N, Elmesmari A, Tange C, Gilmour A, McIntyre D, Kurowska-Stolarska M, McNamee K, Leitner J, Greenwald S, Dassa L, Levine Z, Steinberger P, Williams RO, Miller SD, McInnes IB, Neria E, Rotman G.

J Immunol. 2018 Mar 15;200(6):2025-2037. doi: 10.4049/jimmunol.1700325. Epub 2018 Feb 5.

PMID:
29431694
10.

ILDR2-Fc Is a Novel Regulator of Immune Homeostasis and Inducer of Antigen-Specific Immune Tolerance.

Podojil JR, Hecht I, Chiang MY, Vaknin I, Barbiro I, Novik A, Neria E, Rotman G, Miller SD.

J Immunol. 2018 Mar 15;200(6):2013-2024. doi: 10.4049/jimmunol.1700326. Epub 2018 Feb 5.

PMID:
29431690
11.

Tolerogenic Ag-PLG nanoparticles induce tregs to suppress activated diabetogenic CD4 and CD8 T cells.

Prasad S, Neef T, Xu D, Podojil JR, Getts DR, Shea LD, Miller SD.

J Autoimmun. 2018 May;89:112-124. doi: 10.1016/j.jaut.2017.12.010. Epub 2017 Dec 16.

PMID:
29258717
12.

Pak2 is essential for the function of Foxp3+ regulatory T cells through maintaining a suppressive Treg phenotype.

O'Hagan KL, Miller SD, Phee H.

Sci Rep. 2017 Dec 6;7(1):17097. doi: 10.1038/s41598-017-17078-7.

13.

Using State Birth Defects Registries to Evaluate Regional Critical Congenital Heart Disease Newborn Screening.

Case AP, Miller SD, McClain MR.

Birth Defects Res. 2017 Nov 1;109(18):1414-1422. doi: 10.1002/bdr2.1108.

PMID:
29152920
14.

Conjugation of Transforming Growth Factor Beta to Antigen-Loaded Poly(lactide- co-glycolide) Nanoparticles Enhances Efficiency of Antigen-Specific Tolerance.

Casey LM, Pearson RM, Hughes KR, Liu JMH, Rose JA, North MG, Wang LZ, Lei M, Miller SD, Shea LD.

Bioconjug Chem. 2018 Mar 21;29(3):813-823. doi: 10.1021/acs.bioconjchem.7b00624. Epub 2017 Nov 30.

PMID:
29148731
15.

Pre-metastatic cancer exosomes induce immune surveillance by patrolling monocytes at the metastatic niche.

Plebanek MP, Angeloni NL, Vinokour E, Li J, Henkin A, Martinez-Marin D, Filleur S, Bhowmick R, Henkin J, Miller SD, Ifergan I, Lee Y, Osman I, Thaxton CS, Volpert OV.

Nat Commun. 2017 Nov 6;8(1):1319. doi: 10.1038/s41467-017-01433-3.

16.

Intravenous immune-modifying nanoparticles as a therapy for spinal cord injury in mice.

Jeong SJ, Cooper JG, Ifergan I, McGuire TL, Xu D, Hunter Z, Sharma S, McCarthy D, Miller SD, Kessler JA.

Neurobiol Dis. 2017 Dec;108:73-82. doi: 10.1016/j.nbd.2017.08.006. Epub 2017 Aug 18.

17.

Tolerogenic Nanoparticles to Treat Islet Autoimmunity.

Neef T, Miller SD.

Curr Diab Rep. 2017 Aug 8;17(10):84. doi: 10.1007/s11892-017-0914-z. Review.

18.

Epibiotic pressure contributes to biofouling invader success.

Leonard K, Hewitt CL, Campbell ML, Primo C, Miller SD.

Sci Rep. 2017 Jul 12;7(1):5173. doi: 10.1038/s41598-017-05470-2.

19.

Targeting the GM-CSF receptor for the treatment of CNS autoimmunity.

Ifergan I, Davidson TS, Kebir H, Xu D, Palacios-Macapagal D, Cann J, Rodgers JM, Hunter ZN, Pittet CL, Beddow S, Jones CA, Prat A, Sleeman MA, Miller SD.

J Autoimmun. 2017 Nov;84:1-11. doi: 10.1016/j.jaut.2017.06.005. Epub 2017 Jun 20.

20.

Is Dual Semitendinosus Allograft Stronger Than Turndown for Achilles Tendon Reconstruction? An In Vitro Analysis.

Aynardi MC, Atwater LC, Melvani R, Parks BG, Paez AG, Miller SD.

Clin Orthop Relat Res. 2017 Oct;475(10):2588-2596. doi: 10.1007/s11999-017-5410-x. Epub 2017 Jun 14.

21.

Prevention of hip displacement in children with cerebral palsy: a systematic review.

Miller SD, Juricic M, Hesketh K, Mclean L, Magnuson S, Gasior S, Schaeffer E, O'donnell M, Mulpuri K.

Dev Med Child Neurol. 2017 Nov;59(11):1130-1138. doi: 10.1111/dmcn.13480. Epub 2017 Jun 2. Review.

22.

IL-17 induced NOTCH1 activation in oligodendrocyte progenitor cells enhances proliferation and inflammatory gene expression.

Wang C, Zhang CJ, Martin BN, Bulek K, Kang Z, Zhao J, Bian G, Carman JA, Gao J, Dongre A, Xue H, Miller SD, Qian Y, Hambardzumyan D, Hamilton T, Ransohoff RM, Li X.

Nat Commun. 2017 May 31;8:15508. doi: 10.1038/ncomms15508.

23.

A Rodent Model of Cardiac Donation After Circulatory Death and Novel Biomarkers of Cardiac Viability During Ex Vivo Heart Perfusion.

Kearns MJ, Miller SD, Cheung A, Bashir J, Wong S, Seidman MA, Boyd JH.

Transplantation. 2017 Aug;101(8):e231-e239. doi: 10.1097/TP.0000000000001815.

PMID:
28505025
24.

Controlled Delivery of Single or Multiple Antigens in Tolerogenic Nanoparticles Using Peptide-Polymer Bioconjugates.

Pearson RM, Casey LM, Hughes KR, Wang LZ, North MG, Getts DR, Miller SD, Shea LD.

Mol Ther. 2017 Jul 5;25(7):1655-1664. doi: 10.1016/j.ymthe.2017.04.015. Epub 2017 May 5.

25.

Growing Better Therapists: A New Opportunity for Mental Health Administrators.

Miller SD, Hubble MA, Wampold BE.

Adm Policy Ment Health. 2017 Sep;44(5):732-734. doi: 10.1007/s10488-017-0805-2. No abstract available.

PMID:
28466369
26.

In vivo reprogramming of immune cells: Technologies for induction of antigen-specific tolerance.

Pearson RM, Casey LM, Hughes KR, Miller SD, Shea LD.

Adv Drug Deliv Rev. 2017 May 15;114:240-255. doi: 10.1016/j.addr.2017.04.005. Epub 2017 Apr 14. Review.

27.

Peptide-Conjugated Nanoparticles Reduce Positive Co-stimulatory Expression and T Cell Activity to Induce Tolerance.

Kuo R, Saito E, Miller SD, Shea LD.

Mol Ther. 2017 Jul 5;25(7):1676-1685. doi: 10.1016/j.ymthe.2017.03.032. Epub 2017 Apr 10.

28.

Distribution of Subchondral Bone Puncture Strength in the Talus and Tibial Plafond: A Biomechanical Study.

Ulrich SD, Parks BG, Tsai MA, Miller SD.

Foot Ankle Spec. 2018 Feb;11(1):44-48. doi: 10.1177/1938640017700975. Epub 2017 Mar 28.

PMID:
28347196
29.

Potential targeting of B7-H4 for the treatment of cancer.

Podojil JR, Miller SD.

Immunol Rev. 2017 Mar;276(1):40-51. doi: 10.1111/imr.12530. Review.

30.

Murine Corneal Inflammation and Nerve Damage After Infection With HSV-1 Are Promoted by HVEM and Ameliorated by Immune-Modifying Nanoparticle Therapy.

Edwards RG, Kopp SJ, Ifergan I, Shui JW, Kronenberg M, Miller SD, Longnecker R.

Invest Ophthalmol Vis Sci. 2017 Jan 1;58(1):282-291. doi: 10.1167/iovs.16-20668.

31.

Outcomes After Interpositional Arthroplasty of the First Metatarsophalangeal Joint.

Aynardi MC, Atwater L, Dein EJ, Zahoor T, Schon LC, Miller SD.

Foot Ankle Int. 2017 May;38(5):514-518. doi: 10.1177/1071100716687366. Epub 2017 Jan 9.

PMID:
28068843
32.

Comparison of Suture-Based Anchors and Traditional Bioabsorbable Anchors in Foot and Ankle Surgery.

Hembree WC, Tsai MA, Parks BG, Miller SD.

J Foot Ankle Surg. 2017 Jan - Feb;56(1):3-7. doi: 10.1053/j.jfas.2016.10.011.

PMID:
27989342
33.

Differential Role of B Cells and IL-17 Versus IFN-γ During Early and Late Rejection of Pig Islet Xenografts in Mice.

Kang HK, Wang S, Dangi A, Zhang X, Singh A, Zhang L, Rosati JM, Suarez-Pinzon W, Deng X, Chen X, Thorp EB, Hering BJ, Miller SD, Luo X.

Transplantation. 2017 Aug;101(8):1801-1810. doi: 10.1097/TP.0000000000001489.

34.

In pursuit of truth: A critical examination of meta-analyses of cognitive behavior therapy.

Wampold BE, Flückiger C, Del Re AC, Yulish NE, Frost ND, Pace BT, Goldberg SB, Miller SD, Baardseth TP, Laska KM, Hilsenroth MJ.

Psychother Res. 2017 Jan;27(1):14-32.

PMID:
27884095
35.

Environmental DNA from Residual Saliva for Efficient Noninvasive Genetic Monitoring of Brown Bears (Ursus arctos).

Wheat RE, Allen JM, Miller SD, Wilmers CC, Levi T.

PLoS One. 2016 Nov 9;11(11):e0165259. doi: 10.1371/journal.pone.0165259. eCollection 2016.

36.

An antigen-encapsulating nanoparticle platform for TH1/17 immune tolerance therapy.

McCarthy DP, Yap JW, Harp CT, Song WK, Chen J, Pearson RM, Miller SD, Shea LD.

Nanomedicine. 2017 Jan;13(1):191-200. doi: 10.1016/j.nano.2016.09.007. Epub 2016 Oct 6.

37.

HIF-2α in Resting Macrophages Tempers Mitochondrial Reactive Oxygen Species To Selectively Repress MARCO-Dependent Phagocytosis.

Dehn S, DeBerge M, Yeap XY, Yvan-Charvet L, Fang D, Eltzschig HK, Miller SD, Thorp EB.

J Immunol. 2016 Nov 1;197(9):3639-3649. Epub 2016 Sep 26.

38.

Creating a climate for therapist improvement: A case study of an agency focused on outcomes and deliberate practice.

Goldberg SB, Babins-Wagner R, Rousmaniere T, Berzins S, Hoyt WT, Whipple JL, Miller SD, Wampold BE.

Psychotherapy (Chic). 2016 Sep;53(3):367-75. doi: 10.1037/pst0000060.

PMID:
27631868
39.

Harnessing Nanoparticles for Immune Modulation: (Trends in Immunology 36, 419-427; July 2016).

Getts DR, Shea LD, Miller SD, King NJC.

Trends Immunol. 2016 Oct;37(10):715. doi: 10.1016/j.it.2016.08.003. Epub 2016 Sep 7. No abstract available.

PMID:
27614797
40.

Preliminary validation of the Rating of Outcome Scale and equivalence of ultra-brief measures of well-being.

Seidel JA, Andrews WP, Owen J, Miller SD, Buccino DL.

Psychol Assess. 2017 Jan;29(1):65-75. doi: 10.1037/pas0000311. Epub 2016 Apr 21.

PMID:
27099979
41.

Biodegradable antigen-associated PLG nanoparticles tolerize Th2-mediated allergic airway inflammation pre- and postsensitization.

Smarr CB, Yap WT, Neef TP, Pearson RM, Hunter ZN, Ifergan I, Getts DR, Bryce PJ, Shea LD, Miller SD.

Proc Natl Acad Sci U S A. 2016 May 3;113(18):5059-64. doi: 10.1073/pnas.1505782113. Epub 2016 Apr 18.

42.

Immune Tolerance for Autoimmune Disease and Cell Transplantation.

Luo X, Miller SD, Shea LD.

Annu Rev Biomed Eng. 2016 Jul 11;18:181-205. doi: 10.1146/annurev-bioeng-110315-020137. Epub 2016 Feb 24. Review.

43.

Cutting Edge: MicroRNA-223 Regulates Myeloid Dendritic Cell-Driven Th17 Responses in Experimental Autoimmune Encephalomyelitis.

Ifergan I, Chen S, Zhang B, Miller SD.

J Immunol. 2016 Feb 15;196(4):1455-1459. doi: 10.4049/jimmunol.1501965. Epub 2016 Jan 18.

44.

Cutting Edge: CD99 Is a Novel Therapeutic Target for Control of T Cell-Mediated Central Nervous System Autoimmune Disease.

Winger RC, Harp CT, Chiang MY, Sullivan DP, Watson RL, Weber EW, Podojil JR, Miller SD, Muller WA.

J Immunol. 2016 Feb 15;196(4):1443-8. doi: 10.4049/jimmunol.1501634. Epub 2016 Jan 15.

45.

As good as it gets? Therapy outcomes of trainees over time.

Owen J, Wampold BE, Kopta M, Rousmaniere T, Miller SD.

J Couns Psychol. 2016 Jan;63(1):12-9. doi: 10.1037/cou0000112.

PMID:
26751153
46.

Do psychotherapists improve with time and experience? A longitudinal analysis of outcomes in a clinical setting.

Goldberg SB, Rousmaniere T, Miller SD, Whipple J, Nielsen SL, Hoyt WT, Wampold BE.

J Couns Psychol. 2016 Jan;63(1):1-11. doi: 10.1037/cou0000131.

PMID:
26751152
47.

The working alliance in treatment of military adolescents.

Owen J, Miller SD, Seidel J, Chow D.

J Consult Clin Psychol. 2016 Mar;84(3):200-10. doi: 10.1037/ccp0000035. Epub 2016 Jan 4.

PMID:
26727412
48.

Oligodendrocyte death results in immune-mediated CNS demyelination.

Traka M, Podojil JR, McCarthy DP, Miller SD, Popko B.

Nat Neurosci. 2016 Jan;19(1):65-74. doi: 10.1038/nn.4193. Epub 2015 Dec 14.

49.

Beyond measures and monitoring: Realizing the potential of feedback-informed treatment.

Miller SD, Hubble MA, Chow D, Seidel J.

Psychotherapy (Chic). 2015 Dec;52(4):449-57. doi: 10.1037/pst0000031. Review.

PMID:
26641375
50.

ER Chaperone BiP/GRP78 Is Required for Myelinating Cell Survival and Provides Protection during Experimental Autoimmune Encephalomyelitis.

Hussien Y, Podojil JR, Robinson AP, Lee AS, Miller SD, Popko B.

J Neurosci. 2015 Dec 2;35(48):15921-33. doi: 10.1523/JNEUROSCI.0693-15.2015.

Supplemental Content

Loading ...
Support Center